Publications by authors named "Jeff Liu"

Background: Meningiomas exhibit considerable clinical and biological heterogeneity. We previously identified four distinct molecular groups (immunogenic, NF2-wildtype, hypermetabolic, proliferative) that address much of this heterogeneity. Despite the utility of these groups, the stochasticity of clustering methods and the use of multi-omics data for discovery limits the potential for classifying prospective cases.

View Article and Find Full Text PDF
Article Synopsis
  • Treatment for meningiomas primarily involves surgery and sometimes radiation, but patient responses can vary significantly.
  • Researchers analyzed data from 2,824 meningiomas, including both retrospective and prospective information, to identify molecular biomarkers that predict treatment response.
  • The study found that complete tumor removal and proper treatment of the dural margin significantly improve survival rates, and developed a new molecular model that better predicts how patients will respond to radiotherapy compared to traditional classification methods.
View Article and Find Full Text PDF
Article Synopsis
  • Mutations in isocitrate dehydrogenase (IDH) enzymes in diffuse gliomas are linked to better patient outcomes, but survival rates vary widely among individuals.
  • Researchers analyzed data from 154 patients, revealing that some IDH mutant gliomas had metabolism patterns similar to IDH wild-type tumors, leading to poorer survival rates.
  • The study found that these metabolism-altered IDH mutant tumors had unique epigenetic changes that promoted growth and stem-like characteristics, suggesting new potential treatment targets.
View Article and Find Full Text PDF
Article Synopsis
  • The spread of tumor cells to essential organs significantly contributes to cancer-related deaths.
  • This process, known as metastasis, complicates the treatment and management of various cancers.
  • Understanding the mechanisms behind this spread is crucial for developing better therapies to improve patient outcomes.
View Article and Find Full Text PDF
Article Synopsis
  • - The study investigates the differences in cancer drivers between primary and metastatic breast cancer using genetic techniques in female mice, focusing on mutations involving the Rb gene, which is often inactive in this type of cancer.
  • - Researchers identified specific gene insertion sites (gCIS) that are linked to either primary tumors, metastases, or both, highlighting significant networks related to cancer progression, including a shared MET-RAS network and additional pathways for metastatic cancer.
  • - Analysis of human clinical data reveals that certain genetic factors are more prevalent in primary tumors or metastases, suggesting targeted treatments that inhibit specific signaling pathways (like RB1, MET, and RHO) could help block tumor cell migration and improve outcomes for metastatic breast cancer patients.
View Article and Find Full Text PDF

Immune-mediated anti-tumoral responses, elicited by oncolytic viruses and augmented with checkpoint inhibition, may be an effective treatment approach for glioblastoma. Here in this multicenter phase 1/2 study we evaluated the combination of intratumoral delivery of oncolytic virus DNX-2401 followed by intravenous anti-PD-1 antibody pembrolizumab in recurrent glioblastoma, first in a dose-escalation and then in a dose-expansion phase, in 49 patients. The primary endpoints were overall safety and objective response rate.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the role of CDKN2A/B deletions in grade 3 meningiomas by analyzing 1,577 samples from various cohorts, revealing that homozygous deletions occur in only 7.1% of cases but are linked to significantly poorer patient outcomes.
  • Heterozygous deletions were less common (2.6%) but similarly associated with negative prognoses, while meningiomas with intact CDKN2A/B showed varying outcomes based on CDKN2A mRNA expression.
  • The research highlights a connection between CDKN2A expression, elevated mRNA levels, and aggressive tumor behavior, suggesting that immunohistochemical tests are not reliable for distinguishing between deletion statuses but correlate better
View Article and Find Full Text PDF
Article Synopsis
  • Meningiomas are the most common primary brain tumors in adults, yet historically have received less research attention compared to other CNS tumors, though recent studies have focused on their molecular characteristics.
  • Several independent research groups have integrated genomic and epigenomic data to propose a new molecular classification for meningiomas that may offer better diagnostic accuracy and outcome predictions than traditional histopathological grading.
  • The consensus molecular groups identified include two benign types based on NF2 status, and two aggressive types linked to their hypermetabolic characteristics and cell-cycling pathways, suggesting a need for future validation and standardization for clinical application.
View Article and Find Full Text PDF

Mutations in SFRP4 cause Pyle's bone disease with wide metaphyses and increased skeletal fragility. The WNT signaling pathway plays important roles in determining skeletal architecture and SFRP4 is a secreted Frizzled decoy receptor that inhibits WNT signaling. Seven cohorts of male and female Sfrp4 gene knockout mice, examined through 2 years of age, had a normal lifespan but showed cortical and trabecular bone phenotypes.

View Article and Find Full Text PDF

Unlabelled: Systematically investigating the scores of genes mutated in cancer and discerning disease drivers from inconsequential bystanders is a prerequisite for precision medicine but remains challenging. Here, we developed a somatic CRISPR/Cas9 mutagenesis screen to study 215 recurrent "long-tail" breast cancer genes, which revealed epigenetic regulation as a major tumor-suppressive mechanism. We report that components of the BAP1 and COMPASS-like complexes, including KMT2C/D, KDM6A, BAP1, and ASXL1/2 ("EpiDrivers"), cooperate with PIK3CAH1047R to transform mouse and human breast epithelial cells.

View Article and Find Full Text PDF
Article Synopsis
  • Medulloblastoma (MB) is a major cause of cancer death in children, and there is a need for better models to study how therapy fails during relapses.
  • This study created a patient-derived xenograft (PDX) model of MB that mimics tumor recurrence after treatment, allowing for a deeper understanding of the disease.
  • Researchers identified a new gene, BPIFB4, that is up-regulated following therapy, and targeting it showed promise in reducing MB cell growth and improving survival in models, suggesting new treatment strategies.
View Article and Find Full Text PDF

The critical functions of the human liver are coordinated through the interactions of hepatic parenchymal and non-parenchymal cells. Recent advances in single-cell transcriptional approaches have enabled an examination of the human liver with unprecedented resolution. However, dissociation-related cell perturbation can limit the ability to fully capture the human liver's parenchymal cell fraction, which limits the ability to comprehensively profile this organ.

View Article and Find Full Text PDF
Article Synopsis
  • Meningiomas are the most common primary brain tumors in adults, typically treated with surgery as no effective medications exist.
  • The World Health Organization's grading system and surgical extent do not fully predict the tumor's behavior, highlighting the need for clearer molecular classifications.
  • Recent research identified four consensus molecular groups based on genetic and protein analysis, which better predict clinical outcomes and inform treatment options by revealing distinct biological characteristics.
View Article and Find Full Text PDF
Article Synopsis
  • Management of aggressive meningiomas is complicated, and while PD-L1 immune suppression has been researched in cancer, its role in meningiomas remains unclear.
  • Immunohistochemical analysis revealed that 43% of meningiomas showed PD-L1 expression, indicating a potentially significant prognostic marker for recurrence-free survival.
  • The study also found a strong link between PD-L1, NFKB2, and CA9 expression, especially under hypoxic conditions, suggesting that these markers could help predict tumor progression and warrant further investigation into meningioma's molecular mechanisms.
View Article and Find Full Text PDF

Liver sinusoidal endothelial cells (LSECs) form a highly specialized microvasculature that plays a critical role in liver function and disease. To better understand this role, we developed a strategy to generate LSECs from human pluripotent stem cells (hPSCs) by first optimizing the specification of arterial and venous angioblasts and derivative endothelial populations. Induction of a LSEC-like fate by hypoxia, cyclic AMP (cAMP) agonism, and transforming growth factor β (TGF-β) inhibition revealed that venous endothelial cells responded more rapidly and robustly than the arterial cells to upregulate LSEC markers and functions in vitro.

View Article and Find Full Text PDF

Pineoblastoma is a rare pediatric cancer induced by germline mutations in the tumor suppressors RB1 or DICER1. Presence of leptomeningeal metastases is indicative of poor prognosis. Here we report that inactivation of Rb plus p53 via a WAP-Cre transgene, commonly used to target the mammary gland during pregnancy, induces metastatic pineoblastoma resembling the human disease with 100% penetrance.

View Article and Find Full Text PDF

There is a tremendous focus on the application of nanomaterials for the treatment of cancer. Nonprimate models are conventionally used to assess the biomedical utility of nanomaterials. However, these animals often lack an intact immunological background, and the tumors in these animals do not develop spontaneously.

View Article and Find Full Text PDF

Hip fractures at the femoral neck are a major cause of morbidity and mortality, but aside from biomechanical strength testing, little is known about femoral neck architecture in mice. Procedures were optimized to analyze high-resolution (6 μm voxel size) microCT scans of the mouse femoral neck to provide bone mass and architectural information. Similar to histomorphometric observations in rats, the boundary between cortical and trabecular bone is difficult to identify in the mouse femoral mid-neck and these compartments were not analyzed separately.

View Article and Find Full Text PDF

The disability, mortality and costs caused by non-vertebral osteoporotic fractures are enormous. Existing osteoporosis therapies are highly effective at reducing vertebral but not non-vertebral fractures. Cortical bone is a major determinant of non-vertebral bone strength.

View Article and Find Full Text PDF

During development, multipotent progenitors undergo temporally-restricted differentiation into post-mitotic retinal cells; however, the mechanisms of progenitor division that occurs during retinogenesis remain controversial. Using clonal analyses (lineage tracing and single cell cultures), we identify rod versus cone lineage-specific progenitors derived from both adult retinal stem cells and embryonic neural retinal precursors. Taurine and retinoic acid are shown to act in an instructive and lineage-restricted manner early in the progenitor lineage hierarchy to produce rod-restricted progenitors from stem cell progeny.

View Article and Find Full Text PDF

The liver is the largest solid organ in the body and is critical for metabolic and immune functions. However, little is known about the cells that make up the human liver and its immune microenvironment. Here we report a map of the cellular landscape of the human liver using single-cell RNA sequencing.

View Article and Find Full Text PDF

Purpose: Hexokinase II (HK2) protein expression is elevated in glioblastoma (GBM), and we have shown that HK2 could serve as an effective therapeutic target for GBM. Here, we interrogated compounds that target HK2 effectively and restrict tumor growth in cell lines, patient-derived glioma stem cells (GSCs), and mouse models of GBM. We performed a screen using a set of 15 drugs that were predicted to inhibit the HK2-associated gene signature.

View Article and Find Full Text PDF
Article Synopsis
  • CDC25 is a dual phosphatase that has been identified as a key target for various triple-negative breast cancers, especially those lacking certain genetic features.
  • Inhibitors that block CDC25 show promising results when combined with PI3K inhibitors, leading to better suppression of tumor growth.
  • The text highlights the potential of CDC25 inhibitors in cancer treatment while also addressing the challenges of making these treatments available in clinical settings.
View Article and Find Full Text PDF
Article Synopsis
  • * In triple-negative breast cancer (TNBC), RB1 is often inactivated alongside PTEN and TP53, leading researchers to conduct inhibitor screens on cell lines that lack these tumor suppressors.
  • * The study identified CDC25 phosphatase as a promising therapeutic target, showing that inhibiting CDC25 can suppress the growth of RB1-deficient TNBC cells, especially when combined with WEE1 and PI3K inhibitors.
View Article and Find Full Text PDF